- Home
- GIFT vs DTIL Comparison
GIFT vs DTIL Comparison
Compare GIFT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- DTIL
- Stock Information
- Founded
- GIFT 1999
- DTIL 2006
- Country
- GIFT United States
- DTIL United States
- Employees
- GIFT N/A
- DTIL N/A
- Industry
- GIFT Catalog/Specialty Distribution
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- DTIL Health Care
- Exchange
- GIFT Nasdaq
- DTIL Nasdaq
- Market Cap
- GIFT 55.1M
- DTIL 43.3M
- IPO Year
- GIFT N/A
- DTIL 2019
- Fundamental
- Price
- GIFT $2.05
- DTIL $5.18
- Analyst Decision
- GIFT Strong Buy
- DTIL Strong Buy
- Analyst Count
- GIFT 1
- DTIL 3
- Target Price
- GIFT $4.00
- DTIL $37.67
- AVG Volume (30 Days)
- GIFT 124.6K
- DTIL 126.7K
- Earning Date
- GIFT 03-18-2025
- DTIL 03-26-2025
- Dividend Yield
- GIFT N/A
- DTIL N/A
- EPS Growth
- GIFT N/A
- DTIL N/A
- EPS
- GIFT N/A
- DTIL 1.45
- Revenue
- GIFT $86,439,146.00
- DTIL $75,096,000.00
- Revenue This Year
- GIFT $3.23
- DTIL $51.35
- Revenue Next Year
- GIFT $25.39
- DTIL N/A
- P/E Ratio
- GIFT N/A
- DTIL $2.68
- Revenue Growth
- GIFT N/A
- DTIL 43.62
- 52 Week Low
- GIFT $0.50
- DTIL $3.61
- 52 Week High
- GIFT $4.27
- DTIL $15.97
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- DTIL 48.52
- Support Level
- GIFT N/A
- DTIL $4.69
- Resistance Level
- GIFT N/A
- DTIL $5.33
- Average True Range (ATR)
- GIFT 0.00
- DTIL 0.39
- MACD
- GIFT 0.00
- DTIL -0.04
- Stochastic Oscillator
- GIFT 0.00
- DTIL 34.75
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.